AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtek-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Emphaatic Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimtek-M2 Tablet SR

Diabetic patients utilizing Glimepiride-Metformin extended-release tablets manage their type 2 diabetes through this dual-action medication. This formulation, administered with meals for optimal absorption, effectively regulates blood glucose. Dosage, determined by your physician, may be adjusted based on your glycemic response. Consistent use is crucial; discontinuation without medical supervision risks elevated blood sugar and potential complications like kidney disease, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your healthcare provider. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals, readily available glucose sources (e.g., sugary snacks or juice), and alcohol avoidance are vital preventative measures. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, upper respiratory infections, and weight gain. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should consult their physician before use. Similarly, pregnant or lactating women require medical consultation. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended under your physician's guidance.

Uses of Glimtek-M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimtek-M2 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimtek-M2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimtek-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtek-M2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimtek-M2 Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with a meal.

How Glimtek-M2 Tablet SR works:

Glimtek-M2 SR tablets contain a dual-action formulation of glimepiride and metformin, both used to manage diabetes. Glimepiride, a sulfonylurea agent, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glimtek-M2 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimtek-M2 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Glimtek-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimtek-M2 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function assessments are recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Exercise caution when prescribing Glimtek-M2 SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients experiencing mild to moderate liver dysfunction, initiate Glimtek-M2 SR therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Glimtek-M2 Tablet SR :

Should you forget a Glimtek-M2 Tablet SR dose, take it immediately if you remember. If, however, your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimtek-M2 Tablet SR

LabelValue
Developing Good Habits No.
Type of Therapy Diabetes Management

FAQs on Glimtek-M2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Dispose of any unused medication properly and ensure it's inaccessible to children, pets, and others.
Glimtek-M2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimtek-M2 Tablet SR and seek immediate medical attention.
Glimtek-M2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimtek-M2 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimtek-M2 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimtek-M2 Tablet SR can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimtek-M2 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glimtek-M2 Tablet SR
48
MRP 59
18% off